About Evaluate
Evaluate is a company based in London (United Kingdom) founded in 1996 was acquired by HgCapital Trust in August 2020. It operates as a Data-as-a-Service, and Professional Services. Evaluate has completed 5 acquisitions, including BiosciDB, Bioscience Advisors and Black Swan Analysis. Evaluate offers products and services including Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform. Evaluate operates in a competitive market with competitors including Curatio healthcare, Science and Medicine Group, Kineticos, Cello Health Advantage and J+D Forecasting, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evaluate, A Norstella Company
-
Annual Revenue
$89.89 K (USD)-2as on Dec 31, 2022
-
Net Profit
$16.54 K (USD)-25as on Dec 31, 2022
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
BiosciDB
& 4 more
-
Acquired by
HgCapital Trust
(Aug 04, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evaluate
Evaluate offers a comprehensive portfolio of products and services, including Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Data and insights for pharmaceutical market analysis are provided.
Comprehensive market data for drug development is offered here.
Tools for market sizing and forecasting are made available.
Unlock access to complete
Funding Insights of Evaluate
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2016 | Amount | Private Equity Round - Evaluate | Valuation | HgCapital Trust |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evaluate
Evaluate has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include HgT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are focused on European software firms.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evaluate
Evaluate has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BiosciDB, Bioscience Advisors and Black Swan Analysis. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloud-based database management software is offered for healthcare professionals.
|
2012 | ||||
|
Consulting services for the biopharma sector are provided.
|
2011 | ||||
|
Provider of market analysis & access, data analytics, and consulting services for pharmaceutical sector
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Evaluate
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evaluate Comparisons
Competitors of Evaluate
Evaluate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curatio healthcare, Science and Medicine Group, Kineticos, Cello Health Advantage and J+D Forecasting, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Market research services for biopharma sector are provided.
|
|
| domain | founded_year | HQ Location |
Research and advisory services are provided to life-science companies.
|
|
| domain | founded_year | HQ Location |
Invests in early-stage life sciences companies for innovation, expertise, and growth.
|
|
| domain | founded_year | HQ Location |
Provider of health care data analytics services
|
|
| domain | founded_year | HQ Location |
Pharmaceutical forecasting services are provided for global and local markets.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evaluate
Frequently Asked Questions about Evaluate
When was Evaluate founded?
Evaluate was founded in 1996 and raised its 1st funding round 20 years after it was founded.
Where is Evaluate located?
Evaluate is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
What is the annual revenue of Evaluate?
Annual revenue of Evaluate is $89.89K as on Dec 31, 2022.
What does Evaluate do?
Evaluate is engaged in delivering comprehensive pharmaceutical market intelligence and forecasting solutions. Services are focused on supporting biotech and pharma companies with data-driven insights for drug development, market competition, and portfolio optimization. Sectors covered include biopharma and medtech, with solutions encompassing competitive intelligence, business development, licensing, and custom analytics. A wide range of tools and consulting services are offered to help clients navigate market complexities and make informed strategic decisions.
Who are the top competitors of Evaluate?
Evaluate's top competitors include Curatio healthcare, Cello Health Advantage and Rubix LS.
What products or services does Evaluate offer?
Evaluate offers Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform.
How many acquisitions has Evaluate made?
Evaluate has made 5 acquisitions, including BiosciDB, Bioscience Advisors, and Black Swan Analysis.
Who are Evaluate's investors?
Evaluate has 1 investor. Key investors include HgT.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.